Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-15
2005-02-15
Desai, R (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S322000, C544S370000, C546S199000
Reexamination Certificate
active
06855713
ABSTRACT:
The invention concerns benzimidazole derivatives of the general formula (I)in which the radicals R1, R2, R3, X1and A can have the meanings assigned to them in the specification, their prodrugs, processes for their production as well as the use of the benzimidazole derivatives as medicines, especially as medicines that have trypsin-inhibiting action.
REFERENCES:
patent: 6087380 (2000-07-01), Hauel et al.
patent: 6365584 (2002-04-01), Anderskewitz et al.
patent: 6407130 (2002-06-01), Anderskewitz et al.
patent: 6413990 (2002-07-01), Anderskewitz et al.
patent: 6512000 (2003-01-01), Anderskewitz et al.
patent: WO 0114342 (2001-03-01), None
patent: WO 0134572 (2001-05-01), None
patent: WO 02062785 (2002-08-01), None
Anderskewitz, R. et ali; “Aminocarbonyl-substituted Benzimidazoles Having Tryptase-Inhibitory Activity”; USSN 09/634,958; filed Aug. 8, 2000.
Anderskewitz Ralf
Disse Bernd
Dollinger Horst
Heine Claudia
Hoenke Christoph
Boehringer Ingelheim Pharma KG
Datlow Philip I.
Desai R
Morris Michael
Raymond Robert
LandOfFree
Benzimidazole derivatives, a process for their manufacture... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazole derivatives, a process for their manufacture..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole derivatives, a process for their manufacture... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3465981